High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan

Bone Marrow Transplantation

Volumn 41, Issue 8, 2008, Pages 753-756

  Narimatsu, H ^a   Watanabe, M ^b   Kohno, A ^c   Sugimoto, K ^a   Kuwatsuka, Y ^d   Uchida, T ^e   Murata, M ^a   Miyamura, K ^d   Morishita, Y ^c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^c JA Aichi Showa Hospital   (Japan)

^d JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; COTRIMOXAZOLE; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; PREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; BACTERIAL INFECTION; CANDIDA ALBICANS; CANDIDIASIS; CELL THERAPY; CELLULAR IMMUNITY; CONTINUOUS INFUSION; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DOSE INCREASE; DRUG SAFETY; DRUG TOLERABILITY; ENGRAFTMENT SYNDROME; FATALITY; GASTROINTESTINAL DISEASE; GRAFT FAILURE; GRAM NEGATIVE INFECTION; HEMATOPOIESIS; HERPES VIRUS INFECTION; HUMAN; INCIDENCE; INFECTION; LETTER; LEUKEMIA RELAPSE; LYMPHOMA; MULTIPLE CYCLE TREATMENT; MULTIPLE ORGAN FAILURE; MYCOSIS; MYELODYSPLASTIC SYNDROME; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REDUCED INTENSITY CONDITIONING; RISK REDUCTION; SEPSIS; SKIN DISEASE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS INFECTION; T CELL LEUKEMIA; WHOLE BODY RADIATION;

CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MYELOABLATIVE AGONISTS; PILOT PROJECTS; TRANSPLANTATION CONDITIONING; TREATMENT FAILURE; VIDARABINE;

EID: 42549114246     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705978     Document Type: Letter

References (10)

1. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.
2. Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005; 11: 429-436.
3. Komatsu T, Narimatsu H, Yoshimi A, Kurita N, Kusakabe M, Hori A et al Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan. Ann Hematol 2007; 86: 49-54.
4. Inamoto Y, Oba T, Miyamura K, Terakura S, Tsujimura A, Kuwatsuka Y et al. Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor. Int J Hematol 2006; 83: 356-362.
5. Mizutani E, Narimatsu H, Murata M, Tomita A, Kiyoi H, Naoe T. Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. Bone Marrow Transplant 2007; 40: 85-87.
6. Narimatsu H, Murata M, Sugimoto K, Terakura S, Kinoshita T, Naoe T. Successful umbilical cord blood transplantation using a reduced-intensity preparative regimen without total body irradiation and tacrolimus plus methotrexate for prophylaxis of graft-versus-host disease in a patient with adult T-cell leukemia/lymphoma. Leuk Lymphoma 2007; 48: 841-843.
7. Narimatsu H, Kami M, Miyakoshi S, Murashige N, Yuji K, Hamaki T et al Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2006; 132: 36-41.
8. Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H et al. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant 2007; 39: 31-39.
9. Terakura S, Azuma E, Murata M, Kumamoto T, Hirayama M, Atsuta Y et al Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Biol Blood Marrow Transplant 2007; 13: 822-830.
10. Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960-1969.